Entering text into the input field will update the search result below

ImmunoPrecise Antibodies Ltd. (IPA) CEO Jennifer Bath on Q4 2021 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2021 Earnings Conference Call July 28, 2021 4:30 PM ET

Company Participants

John Mullaly - LifeSci Advisors

Jennifer Bath - President & Chief Executive Officer

Lisa Helbling - Chief Financial Officer

Conference Call Participants


Good afternoon ladies and gentlemen and thank you for standing by. Welcome to ImmunoPrecise Antibodies Financial Results and Business Highlights Earnings Call for the Full Fiscal Year 2021. At this time, all participants are in a listen-only mode. Following the presentation, we will answer pre-submitted questions. [Operator Instructions] I would like to remind everyone that this conference call is being recorded today, Wednesday, July 28, 2021, at 4:30 P.M. Eastern Time.

I will now turn the call over to John. John, please go ahead.

John Mullaly

Thank you and welcome. Dr. Jennifer Bath, President and Chief Executive Officer of ImmunoPrecise Antibodies and Ms. Lisa Helbling, Chief Financial Officer will be the speakers on today's call. A Q&A period answering pre-submitted questions will follow their earnings report followed by closing remarks.

Before Dr. Bath begins, I have been asked by ImmunoPrecise Antibodies to read the following Safe Harbor regarding forward-looking statements. I would like to remind everyone that ImmunoPrecise's remarks today contain forward-looking statements about its current and future plans, expectations, and intentions, results, levels of activity, performance, goals, or achievements, or other future events or developments.

In preparing these forward-looking statements, several assumptions were made by ImmunoPrecise and there are risks that results actually obtained by the company will differ materially from those statements. As a consequence, the company cannot guarantee that any forward-looking statement will materialize and you are cautioned not to place undue reliance on them.

ImmunoPrecise refers current and potential investors to the forward-looking Information section or its management discussion and analysis issued today at www.sedar.com and

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.